U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C12H19NO3.ClH
Molecular Weight 261.745
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PRENALTEROL HYDROCHLORIDE

SMILES

Cl.CC(C)NC[C@H](O)COC1=CC=C(O)C=C1

InChI

InChIKey=WDXYIFGETVGLBZ-MERQFXBCSA-N
InChI=1S/C12H19NO3.ClH/c1-9(2)13-7-11(15)8-16-12-5-3-10(14)4-6-12;/h3-6,9,11,13-15H,7-8H2,1-2H3;1H/t11-;/m0./s1

HIDE SMILES / InChI

Molecular Formula C12H19NO3
Molecular Weight 225.2842
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
280.0 nM [Ki]

PubMed

Sample Use Guides

In Vivo Use Guide
The eight patients were given prenalterol (PNL) orally, 30 to 200 mg/day, versus placebo for 6 days
Route of Administration: Oral
Substance Class Chemical
Record UNII
U6VH18LCQ8
Record Status Validated (UNII)
Record Version